Fosun Pharma
600196.SS
#1990
Rank
NZ$17.09 B
Marketcap
NZ$6.40
Share price
1.14%
Change (1 day)
9.18%
Change (1 year)

Earnings for Fosun Pharma (600196.SS)

Earnings in 2025 (TTM): NZ$1.16 Billion

According to Fosun Pharma's latest financial reports the company's current earnings are NZ$5.58 Billion. In 2024 the company made an earning of NZ$0.96 Billion, an increase over its 2023 earnings that were of NZ$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fosun Pharma from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$1.16 B20.42%
2024 NZ$0.96 B25.44%
2023 NZ$0.77 B-31.53%
2022 NZ$1.12 B-28.08%
2021 NZ$1.56 B37.28%
2020 NZ$1.14 B4.48%
2019 NZ$1.09 B21.16%
2018 NZ$0.90 B-10.83%
2017 NZ$1.01 B12.72%
2016 NZ$0.89 B0.24%
2015 NZ$0.89 B22.63%
2014 NZ$0.72 B-8.16%
2013 NZ$0.79 B40.92%
2012 NZ$0.56 B25.97%
2011 NZ$0.44 B50.49%
2010 NZ$0.29 B-62.8%
2009 NZ$0.79 B294.46%
2008 NZ$0.20 B19.26%
2007 NZ$0.16 B136.37%
2006 NZ$71.82 M31.44%
2005 NZ$54.64 M-13.45%
2004 NZ$63.14 M-10.03%
2003 NZ$70.18 M98.84%
2002 NZ$35.29 M